Aim: The current study was designed to isolate and characterize Toxocara vitulorum glycoprotein antigens and then to evaluate its potency in accurate diagnosis of toxocariasis.

Materials and Methods: T. vitulorum glycoprotein fractions were isolated using Con-A affinity chromatography. The fractions characterized using sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and immunoblot assay. Mass spectrometric analysis was used for identification of proposed structure of the N-acetylglucosamine (GlcNAc) fraction. Enzyme-linked immunosorbent assay (ELISA) was used to assess the diagnostic potential of the isolated fractions.

Results: Surface of T. vitulorum adult worm revealed two glycoprotein fractions rich in glucose (Glc) and GlcNAc. Three bands of molecular weight 212kDa, 107 kDa, and 93 kDa were detected in Glc fraction by SDS-PAGE. These bands were also detected in GlcNAc fraction with an additional band of 49 kDa. GlcNAc fraction showed more diagnostic potency of calves' toxocariasis; 79% than Glc fraction; 46.9% by indirect ELISA. The additional band of 49 kDa in GlcNAc fraction is probably responsible for its higher diagnostic potentials. Western blotting verified the immunoreactivity of the Glc and GlcNAc isolated fraction as they reacted with calves sera infected with toxocariasis. The proposed structure of GlcNAc fraction was Ser-Meth-Arg-O-methylated GlcNAc.

Conclusion: GlcNAc-rich fraction of T. vitulorum can be successfully utilized in the diagnosis of calves' toxocariasis.

Keywords: affinity chromatography, calves toxocariasis, Con A, enzyme-linked immunosorbent assay, mass spectrometric analysis, N-acetylglucosamine.

1. Rizkm, M.A., Osman, S.A., AL-Gaabary, M.H. and EL-Khodery, S.A. (2018) Comparative clinical and parasitological efficacy of moxidectin pour-on, ivermectin, and piperazine citrate on Toxocara vitulorum infection in buffalo calves (Bubalus bubalis): A randomized clinical trial. Turk. J. Vet. Anim. Sci., 42(1): 29-33. [Crossref]

2. Abdel-Rahman, M.A.M. and El-Menyawe, S.M. (2015) A review of toxocariasis in man and animal. Egypt. J. Chem. Environ. Health, 1(1): 315-330.

3. Kim, H.B., Seo, J.W., Lee, J.H., Choi, B.S. and Park, S.G. (2017) Evaluation of the prevalence and clinical impact of toxocariasis in patients with eosinophilia of unknown origin. Korean J. Intern. Med., 32(3): 523-529. [Crossref] [PubMed] [PMC]

4. Van Der Steen, L., Pardon, B., Sarre, C., Valgaeren, B., Van Hende, D., Vlaminck, L. and Deprez, P. (2014) Intestinal obstruction by Toxocara vitulorum in a calf. Vlaams Diergeneeskund. Tijdschr., 83(6): 300-305.

5. Report of a Joint FAO/WHO Expert Meeting (2012) Multicriteria-Based Ranking for Risk Management of Food-Borne Parasites. FAO Headquarters, Rome, Italy.

6. de Souza, E.M., Starke-Buzetti, W.A., Ferreira, F.P., Neves, M.F. and Machado, R.Z. (2004) Humoral immune response of water buffalo monitored with three different antigens of Toxocara vitulorum. Vet. Parasitol., 122(1): 67-78. [Crossref] [PubMed]

7. Hassan, S.E. and Aziz, M.M.A. (2010) Detection of antibodies to excretory-secretory antigen of Toxocara vitulorum infective larvae in the buffalo calves by ELISA. Glob. Vet., 4(1): 97-102.

8. Devika, I., Ehambaram, K. and Bandara, P. (2017) Prevalence of Toxocara antibodies among patients clinically suspected to have ocular toxocariasis: A retrospective descriptive study in Sri Lanka. BMC Ophthalmol., 17(1): 50. [Crossref] [PubMed] [PMC]

9. Koizumi, A., Yamano, K., Tsuchiya, T., Schweizer, F., Kiuchi, F. and Hada, N. (2012) Synthesis, antigenicity against human sera and structure-activity relationships of carbohydrate moieties from Toxocara larvae and their analogs. Molecules, 17(8): 9023-9042. [Crossref] [PubMed] [PMC]

10. Dlugosz, E. and Wisniewski, M. (2016) Toxocara canis Glycans influence antigen recognition by mouse IgG1 and IgM antibodies. Acta Parasitol., 61(1): 191-194. [Crossref]

11. Hewitson, J.P., Nguyen, D.L., van Diepen, A., Smit, C.H., Koeleman, C.A., McSorley, H.J., Murray, J., Maizels, R.M. and Hokke, C.H.(2016) Novel O-linked methylated glycan antigens decorate secreted immunodominant glycoproteins from the intestinal nematode Heligmosomoide spolygyrus. Int. J. Parasitol., 46(3): 157-170. [Crossref] [PubMed] [PMC]

12. Paschinger, K. and Wilson, I.B.H. (2014) Comparative glycobiology. In: Glycoscience: Biology and Medicine. Springer, Tokyo Heidelberg New York Dordrecht London. p1-11. [Crossref]

13. Akao, N. and Ohta, N. (2007) Toxocariasis in Japan. Parasitol. Int., 56(2): 87-93. [Crossref] [PubMed]

14. Maizels, R.M. (2013) Toxocara canis: Molecular basis of immune recognition and evasion. Vet. Parasitol., 193(4): 365-374. [Crossref] [PubMed] [PMC]

15. Zhan, B., Ajmera, R., Geiger, S.M., Goncalves, M.T.P., Liu, Z., Wei, J., Wilkins, P.P., Fujiwara, R., Gazzinelli-Guimaraes, P.H., Bottazzi, M.E., Hotez, P. (2015) Identification of immunodominant antigens for the laboratory diagnosis of toxocariasis. Trop. Med. Int. Health, 20(12): 1787-1796. [Crossref] [PubMed]

16. Meghji, M. and Maizels, R.M. (1986) Biochemical properties of larval excretory-secretory (ES) glycoproteins of the parasitic nematode Toxocara canis. Mol. Biochem. Parasitol., 18(2): 155-170. [Crossref]

17. Khoo, K.H., Maizels, R.M., Page, A.P., Taylor, G.W., Rendell, N.B. and Dell, A. (1991) Characterization of nematode glycoproteins: The major O-glycans of Toxocara excretory-secretory antigens are O-methylated trisaccharides. Glycobiology, 1(2): 163-171. [Crossref]

18. Schabussova, I., Amer, H., van Die, I., Kosma, P. and Maizels, R.M. (2007) O-Methylated glycans from Toxocara are specific targets for antibody binding in human and animal infections. Int. J. Parasitol., 37(1): 97-109. [Crossref] [PubMed]

19. Khoo, K.H., Morris, H.R. and Dell, A. (1993) Structural characterization of the major glycans of Toxocara canis ES antigens. In: Lewis, J., Maizels, R.M., editors. Toxocara and Toxocariasis: Clinical, Epidemiological and Molecular Perspectives. Institute of Biology, London. p133-140.

20. Lowry, O.H., Rosebrough, N.J., Farr, A.L. and Randall, R.J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem., 193(1): 265-275. [PubMed]

21. Abdel-Rahman, E.H., Mohamed, A.-H., Abdel-Rahman, A.A.H. and El Shanawany, E.E. (2016) The role of ser-(Arg-Ser-Arg-Ser-GlcNAc)19- GlcNAc Fasciola gigantica glycoprotein in the diagnosis of prepatent fasciolosis in rabbits. J. Parasit. Dis., 40(1): 11-21. [Crossref] [PubMed] [PMC]

22. Laemmli, U.K. (1970) Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227(5259): 680-685. [Crossref]

23. Wray, W., Boulikas, T., Wray, V.P. and Hancock, R. (1981) Silver staining of proteins in polyacrylamide gels. Anal. Biochem., 118(1): 197-203. [Crossref]

24. Towbin, H., Stachelin, T. and Gordon, J. (1979) Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc. Natl. Acad. Sci., 76(9): 4350-4354. [Crossref]

25. Oldham, G. (1983) Antibodies to Fasciola hepatica antigens during experimental infections in cattle measured by ELISA. Vet. Parasitol., 13(2): 151-158. [Crossref]

26. Almazan, C., Avila, G., Quiroz, H., Ibarra, F. and Ochoa, P. (2001) Effect of parasite burden on detection of Fasciola hepatica antigens in sera and feces of experimentally infected sheep. Vet. Parasitol., 97(2): 101-112. [Crossref]

27. Parikh, R., Mathai, A., Parikh, S., Sekhar, G.C. and Thomas, R. (2008) Understanding and using sensitivity, specificity and predictive values. Indian J. Ophthalmol., 56(1): 45-50. [Crossref]

28. Van Die, I. and Cummings, R.D. (2010) Glycan gimmickry by parasitic helminths: A strategy for modulating the host immune response? Glycobiology, 20(1): 2-12. [Crossref] [PubMed]

29. Prasanphanich, N.S., Mickum, M.L., Heimburg-Molinaro, J. and Cummings, R.D. (2013) Glycoconjugates in host-helminth interactions. Front. Immunol., 4(240):1-22. [Crossref]

30. Lewis, J.W. and Maizels, R.M. (1993) Toxocara and Toxocariasis: Clinical, epidemiological and molecular perspectives. London: The British Society for Parasitology and the Institute of Biology. Trans. R. Soc. Trop. Med. Hyg., 88(4): 494-495.

31. Maizels, R.M. and Page, A.P. (1990) Surface associated glycoproteins from toxocaracanis L2 parasites. Acta Trop., 47(5-6): 355-364. [Crossref]

32. Rubinsky-Elefant, G., Shimizu, S.H., Sanchez, M.C.A., Jacob, C.M.A. and Ferreira, A.W. (2006) A serological follow-up of toxocariasis patients after chemotherapy based on the detection of IgG, IgA, and IgE antibodies by enzyme-linked immunosorbent assay. J. Clin. Lab. Anal., 20(4): 164-172. [Crossref] [PubMed]

33. Carbon, F.R. and Gleeson, P.A. (1997) Carbohydrates and antigen recognition by T cells. Glycobiology, 7(6): 725-730. [Crossref]

34. Bachmann, M.F. and Dyer, M.R. (2004) Therapeutic vaccination for chronic diseases: A new class of drugs in sight. Nat. Rev. Drug Discov., 3(1): 81-88. [Crossref] [PubMed]

35. Lee, C.J., Lee, L.H. and Koizumi, K. (2002) Polysaccharide vaccines for prevention of encapsulated bacterial infections: Part 2. Infect. Med., 19(4): 179-182.

36. Lee, C.J., Lee, L.H. and Koizumi, K. (2002) Polysaccharide vaccines for prevention of encapsulated bacterial infections: Part 1. Infect. Med., 19(3): 127-133.

37. Oliver-Gonzalez, J. and Torregossa, M.V. (1944) A substance in animal parasites related to the human isoagglutinins. J. Infect. Dis., 14(3): 173-177. [Crossref]

38. Soulsby, E.J.L. and Coombs, R.R.A. (1959) Studies on blood group substances associated with Ascaris lumbricoides. Parasitology, 49(3-4): 505-510. [Crossref]

39. Smith, H.V., Kusel, J.R. and Girdwood, R.W.A. (1983) The production of human A and B blood group like substances by in vitro maintained second stage Toxocara canis larvae: Their presence on the outer larval surfaces and in their excretions/secretions. Clin. Exp. Immunol., 54(3): 625-633. [PubMed] [PMC]

40. Smith, H.V., Girdwood, R.W.A. and Kusel, J.R. (1984) Misinterpretation of Toxocara serodiagnostic tests. Br. Med. J., 288(6425): 1235. [Crossref]